| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant microRNA expression pattern in myelodysplastic bone marrow cells
|
Hussein, Kais
|
|
2010
|
34 |
9 |
p. 1169-1174
6 p.
|
artikel
|
| 2 |
A case of hemolytic anemia and severe thrombocytopenia related to histiocytic sarcoma
|
Patel, Sandip
|
|
2010
|
34 |
9 |
p. e257-e258
nvt p.
|
artikel
|
| 3 |
A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia
|
Lazarevic, Vladimir Lj
|
|
2010
|
34 |
9 |
p. 1253-
1 p.
|
artikel
|
| 4 |
A novel case of acute myeloid leukemia with RUNX1/RUNX1T1 rearrangement in Klinefelter syndrome
|
Lim, Gayoung
|
|
2010
|
34 |
9 |
p. e259-e260
nvt p.
|
artikel
|
| 5 |
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib
|
Cea, Michele
|
|
2010
|
34 |
9 |
p. e240-e242
nvt p.
|
artikel
|
| 6 |
Bcr–Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs)
|
Kalle, Arunasree M.
|
|
2010
|
34 |
9 |
p. 1132-1138
7 p.
|
artikel
|
| 7 |
CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma
|
Jevremovic, Dragan
|
|
2010
|
34 |
9 |
p. 1235-1238
4 p.
|
artikel
|
| 8 |
CD34+/CD38− cells and minimal residual disease in childhood lymphoblastic leukemia
|
DiGiuseppe, Joseph A.
|
|
2010
|
34 |
9 |
p. 1125-1126
2 p.
|
artikel
|
| 9 |
Changes in oncomiR expression in CTCL cell lines during apoptosis induced by Notch inhibition
|
Manfè, Valentina
|
|
2010
|
34 |
9 |
p. e235-e236
nvt p.
|
artikel
|
| 10 |
Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report
|
Yun, Jina
|
|
2010
|
34 |
9 |
p. 1175-1179
5 p.
|
artikel
|
| 11 |
Co-existence of paroxysmal nocturnal hemoglobinuria and antiphospholipid syndrome—A role for complement activation
|
Grossman, Alon
|
|
2010
|
34 |
9 |
p. e251-e253
nvt p.
|
artikel
|
| 12 |
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma
|
Jagannath, Sundar
|
|
2010
|
34 |
9 |
p. 1111-1118
8 p.
|
artikel
|
| 13 |
Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression
|
Papageorgiou, Sotirios G.
|
|
2010
|
34 |
9 |
p. e254-e256
nvt p.
|
artikel
|
| 14 |
Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation
|
Li, Qing
|
|
2010
|
34 |
9 |
p. 1158-1168
11 p.
|
artikel
|
| 15 |
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
|
Gattermann, Norbert
|
|
2010
|
34 |
9 |
p. 1143-1150
8 p.
|
artikel
|
| 16 |
Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood
|
Han, Mi Hwa
|
|
2010
|
34 |
9 |
p. 1127-1131
5 p.
|
artikel
|
| 17 |
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy
|
Belada, David
|
|
2010
|
34 |
9 |
p. e232-e234
nvt p.
|
artikel
|
| 18 |
Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
|
Barosi, Giovanni
|
|
2010
|
34 |
9 |
p. 1119-1120
2 p.
|
artikel
|
| 19 |
Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
|
Galván, Ana Belén
|
|
2010
|
34 |
9 |
p. 1242-1245
4 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
2010
|
34 |
9 |
p. CO2-
1 p.
|
artikel
|
| 21 |
Expression of syncytin in leukemia and lymphoma cells
|
Sun, Yi
|
|
2010
|
34 |
9 |
p. 1195-1202
8 p.
|
artikel
|
| 22 |
FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy
|
Ueda, Koki
|
|
2010
|
34 |
9 |
p. 1239-1241
3 p.
|
artikel
|
| 23 |
Gemtuzumab ozogamicin (Mylotarg®) upregulates tissue factor expression but not secretion of inflammatory cytokines TNF-α or IL-8
|
Bruneau, Johanna C.
|
|
2010
|
34 |
9 |
p. 1232-1234
3 p.
|
artikel
|
| 24 |
High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia
|
Ebinger, Martin
|
|
2010
|
34 |
9 |
p. 1139-1142
4 p.
|
artikel
|
| 25 |
Hyperlipidemia in a myeloma patient after bortezomib treatment
|
Gozzetti, Alessandro
|
|
2010
|
34 |
9 |
p. e250-
1 p.
|
artikel
|
| 26 |
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
|
Wolf, Armin
|
|
2010
|
34 |
9 |
p. 1180-1188
9 p.
|
artikel
|
| 27 |
Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts
|
Lim, Wah-Seng
|
|
2010
|
34 |
9 |
p. 1214-1223
10 p.
|
artikel
|
| 28 |
MAGE, biological functions and potential clinical applications
|
Miranda, Enrique I.
|
|
2010
|
34 |
9 |
p. 1121-1122
2 p.
|
artikel
|
| 29 |
Multicenter phase II trial of vitamin K2 monotherapy and vitamin K2 plus 1α-hydroxyvitamin D3 combination therapy for low-risk myelodysplastic syndromes
|
Akiyama, Nobu
|
|
2010
|
34 |
9 |
p. 1151-1157
7 p.
|
artikel
|
| 30 |
[No title]
|
Bennett, John M.
|
|
2010
|
34 |
9 |
p. 1252-
1 p.
|
artikel
|
| 31 |
Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate
|
Anthony, Navin
|
|
2010
|
34 |
9 |
p. 1250-1251
2 p.
|
artikel
|
| 32 |
Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration
|
Papayannidis, Cristina
|
|
2010
|
34 |
9 |
p. e246-e247
nvt p.
|
artikel
|
| 33 |
PML/RAR-α fusion transcript and polyploidy in acute promyelocytic leukemia without t(15;17)
|
Soriani, Silvia
|
|
2010
|
34 |
9 |
p. e261-e263
nvt p.
|
artikel
|
| 34 |
Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag
|
Erickson-Miller, Connie L.
|
|
2010
|
34 |
9 |
p. 1224-1231
8 p.
|
artikel
|
| 35 |
Successful treatment using low-dose dasatinib for chronic myelogenous leukemia in a patient with megakaryoblastic transformation concomitant with myelofibrosis and an extramedullary tumor
|
Yamaguchi, Masaki
|
|
2010
|
34 |
9 |
p. e237-e239
nvt p.
|
artikel
|
| 36 |
Sustained cytokinemia and chemokinemia concomitant with juvenile myelomonocytic leukemia in an infant with Noonan syndrome
|
Okazaki, Kaoru
|
|
2010
|
34 |
9 |
p. e226-e228
nvt p.
|
artikel
|
| 37 |
Syk expression patterns differ among B-cell lymphomas
|
Ponzoni, Maurilio
|
|
2010
|
34 |
9 |
p. e243-e245
nvt p.
|
artikel
|
| 38 |
Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature
|
Kata, Dariusz
|
|
2010
|
34 |
9 |
p. e229-e231
nvt p.
|
artikel
|
| 39 |
The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia
|
Tarnani, Michela
|
|
2010
|
34 |
9 |
p. 1189-1194
6 p.
|
artikel
|
| 40 |
Therapeutic options for patients with myelofibrosis in blast phase
|
Mascarenhas, John
|
|
2010
|
34 |
9 |
p. 1246-1249
4 p.
|
artikel
|
| 41 |
The significance of elevated beta 2-microglobulin (b2-m) in chronic lymphocytic leukemia (CLL): Evidence of in vitro secretion following activation of CLL cells
|
Berrebi, Alain
|
|
2010
|
34 |
9 |
p. e248-e249
nvt p.
|
artikel
|
| 42 |
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1
|
Oakford, Phillippa C.
|
|
2010
|
34 |
9 |
p. 1203-1213
11 p.
|
artikel
|
| 43 |
Treating imatinib resistance in the few in CML—A key step towards cure in all
|
Giles, Francis J.
|
|
2010
|
34 |
9 |
p. 1123-1124
2 p.
|
artikel
|
Tijdschrift beschrijving